BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 3072463)

  • 1. Contribution of Haemophilus influenzae type b lipopolysaccharide to pathogenesis of infection.
    Kaplan SL; Hawkins EP; Inzana TJ; Patrick CC; Mason EO
    Microb Pathog; 1988 Jul; 5(1):55-62. PubMed ID: 3072463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antigenic and phenotypic variations of Haemophilus influenzae type b lipopolysaccharide and their relationship to virulence.
    Kimura A; Hansen EJ
    Infect Immun; 1986 Jan; 51(1):69-79. PubMed ID: 3484459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of mutations in lipooligosaccharide biosynthesis genes on virulence of Haemophilus influenzae type b.
    Cope LD; Yogev R; Mertsola J; Argyle JC; McCracken GH; Hansen EJ
    Infect Immun; 1990 Jul; 58(7):2343-51. PubMed ID: 1694825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of potentiation of experimental Haemophilus influenzae type B disease in infant rats by influenza A virus.
    Myerowitz RL; Michaels RH
    Lab Invest; 1981 May; 44(5):434-41. PubMed ID: 6971959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unexpected effects of absorbed normal rabbit serum and bovine serum albumin on survival of Haemophilus influenzae type b in the infant rat.
    Loeb MR
    Microb Pathog; 1988 Jan; 4(1):9-13. PubMed ID: 3264378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase-variable lipopolysaccharide structures enhance the invasive capacity of Haemophilus influenzae.
    Weiser JN; Williams A; Moxon ER
    Infect Immun; 1990 Oct; 58(10):3455-7. PubMed ID: 2401571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-CD11b monoclonal antibody in an infant rat model of Haemophilus influenzae type b sepsis and meningitis.
    Tan TQ; Smith CW; Hawkins EP; Kaplan SL
    J Antimicrob Chemother; 1997 Feb; 39(2):209-16. PubMed ID: 9069541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of intravascular replication in the pathogenesis of experimental bacteremia due to Haemophilus influenzae type b.
    Rubin LG; Zwahlen A; Moxon ER
    J Infect Dis; 1985 Aug; 152(2):307-14. PubMed ID: 3875663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The type b capsular polysaccharide as a virulence determinant of Haemophilus influenzae: studies using clinical isolates and laboratory transformants.
    Moxon ER; Vaughn KA
    J Infect Dis; 1981 Apr; 143(4):517-24. PubMed ID: 6972419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of mutations in genes required for lipopolysaccharide synthesis on Haemophilus influenzae type b colonization of human nasopharyngeal tissue.
    Jackson AD; Maskell D; Moxon ER; Wilson R
    Microb Pathog; 1996 Dec; 21(6):463-70. PubMed ID: 8971686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-capsular polysaccharide antibodies reduce nasopharyngeal colonization by Haemophilus influenzae type b in infant rats.
    Kauppi M; Saarinen L; Käyhty H
    J Infect Dis; 1993 Feb; 167(2):365-71. PubMed ID: 8421170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The infant rat as a model of bacterial meningitis.
    Moxon ER; Glode MP; Sutton A; Robbins JB
    J Infect Dis; 1977 Aug; 136 Suppl():S186-90. PubMed ID: 330777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoclonal anti-LPS inner core antibodies protect against experimental hematogenous Haemophilus influenzae type b meningitis.
    Borrelli S; Diab A; Lindberg A; Svanborg C
    Microb Pathog; 2000 Jan; 28(1):1-8. PubMed ID: 10623558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Haemophilus influenzae b bacteremia and meningitis in infant rabbits after intranasal inoculation.
    San Joaquin VH; Altshuler GP; Robinson W; Marks MI; Weber A
    J Lab Clin Med; 1983 Dec; 102(6):939-46. PubMed ID: 6606008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contribution of lipopolysaccharide to pathogenicity of Haemophilus influenzae: comparative virulence of genetically-related strains in rats.
    Zwahlen A; Rubin LG; Moxon ER
    Microb Pathog; 1986 Oct; 1(5):465-73. PubMed ID: 3509884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of immunity against lethal Haemophilus influenzae type b infection by Escherichia coli core lipopolysaccharide.
    Marks MI; Ziegler EJ; Douglas H; Corbeil LB; Braude AI
    J Clin Invest; 1982 Apr; 69(4):742-9. PubMed ID: 7042755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Haemophilus influenzae outer membrane vesicle-induced blood-brain barrier permeability during experimental meningitis.
    Wispelwey B; Hansen EJ; Scheld WM
    Infect Immun; 1989 Aug; 57(8):2559-62. PubMed ID: 2787292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative virulence of Haemophilus influenzae with a type b or type d capsule.
    Roberts M; Stull TL; Smith AL
    Infect Immun; 1981 May; 32(2):518-24. PubMed ID: 6972914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intraperitoneal inoculation of Haemophilus influenzae local isolates in BALB/c mice model in the presence and absence of virulence enhancement agents.
    Mojgani N; Maldjae V; Rahbar M; Mirafzali SM; Khoshnood S; Hatami A
    Indian J Med Microbiol; 2013; 31(2):148-53. PubMed ID: 23867671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential complement resistance mediates virulence of Haemophilus influenzae type b.
    Sutton A; Schneerson R; Kendall-Morris S; Robbins JB
    Infect Immun; 1982 Jan; 35(1):95-104. PubMed ID: 6976328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.